Search form

Topics:

ubmslateCL-logo-ubm

CL Mobile Menu

Diabetes Type 2

SGLT2 Inhibitor Q & A

Four questions for you to answer, four facts you need to know.

 

Diabetes Type 2

Providers may now be paid up to $785 (increased from $450) for each patient who loses 5% of their body weight.

Help your patients with diabetes help themselves. See 5 apps at-a-glance you can discuss at the next visit.

Study: each gain of 5 kg was linked to a 17% drop in odds of healthy aging. A powerful message for young patients.

Studies summarized in this slide show focus on fine-tuning insulin-containing regimens to enhance glucose control and avoid variability.

Glycemic variability fuels hypoglycemia but in one study from ADA 2017 is found to actually help predict hypoglycemic events.

Cardiovascular risk/benefit profiles of pioglitazone and the SGLT2 inhibitor class are summarized, based on reports at ADA 2017.

A1C vs FPG to diagnose prediabetes; prediabetes and CHF; and how much weight loss is too much? Reports from ADA 2017.

Pages

Subscribe to Diabetes Type 2 on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.